Lonza Group AG is a Switzerland-based healthcare manufacturing company that makes biologics and other products for the biopharma industry. Its recent lobbying focuses on issues that affect healthcare manufacturing, including supply chains, intellectual property, international trade, and tariffs. Filings show three reports totaling $220,000 and the firm hired Brownstein Hyatt Farber Schreck LLP to represent it.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
AARON CUMMINGS
The latest disclosures for this client.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q3BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
SCOTT DOUGLAS
BROWNSTEIN HYATT FARBER SCHRECK, LLP
STEPHEN HOLLAND
BROWNSTEIN HYATT FARBER SCHRECK, LLP
TIM SHADYAC
BROWNSTEIN HYATT FARBER SCHRECK, LLP
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q1BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q4BROWNSTEIN HYATT FARBER SCHRECK, LLP
Q3BROWNSTEIN HYATT FARBER SCHRECK, LLP
RR